{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T11:02:27Z","timestamp":1785322947351,"version":"3.55.0"},"reference-count":57,"publisher":"Baskent University","issue":"Supp 2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Clin Transplant"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.6002\/ect.mesot2025.p191","type":"journal-issue","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T11:36:06Z","timestamp":1785238566000},"source":"Crossref","is-referenced-by-count":0,"title":[],"prefix":"10.6002","volume":"24","member":"4021","reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"1. Jahromi M, Al-Otaibi T, Ashry Gheith O, et al. Analysis of the frequency of single nucleotide polymorphisms in cytokine genes in patients with new onset diabetes after transplant. Sci Rep. 2021;11(1):6014. doi:10.1038\/s41598-021-84400-9","DOI":"10.1038\/s41598-021-84400-9"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"2. Ussif AM, \u00c5sberg A, Halden TAS, Nordheim E, Hartmann A, Jenssen T. Validation of diagnostic utility of fasting plasma glucose and HbA1c in stable renal transplant recipients one year after transplantation. BMC Nephrol. 2019;20(1):12. doi:10.1186\/s12882-018-1171-3","DOI":"10.1186\/s12882-018-1171-3"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"3. Kurnikowski A, Nordheim E, Schwaiger E, et al. Criteria for prediabetes and posttransplant diabetes mellitus after kidney transplantation: a 2-year diagnostic accuracy study of participants from a randomized controlled trial. Am J Transplant. 2022;22(12):2880-2891. doi:10.1111\/ajt.17187","DOI":"10.1111\/ajt.17187"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"4. Porrini E, Diaz JM, Moreso F, et al. Prediabetes is a risk factor for cardiovascular disease following renal transplantation. Kidney Int. 2019;96:1374-1380. doi:10.1016\/j.kint.2019.06.026","DOI":"10.1016\/j.kint.2019.06.026"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"5. Singer J, Aouad LJ, Wyburn K, Gracey DM, Ying T, Chadban SJ. The utility of pre- and post-transplant oral glucose tolerance tests: identifying kidney transplant recipients with or at risk of new onset diabetes after transplant. Transpl Int. 2022;35:10078. doi:10.3389\/ti.2022.10078","DOI":"10.3389\/ti.2022.10078"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"6. American Diabetes Association Professional Practice Committee. 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes-2024. Diabetes Care. 2024;47(Suppl 1):S20-S42. doi:10.2337\/dc24-S002","DOI":"10.2337\/dc24-S002"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"7. Wang R, Yang M, Jiang L, Huang M. Role of Angiopoietin-Tie axis in vascular and lymphatic systems and therapeutic interventions. Pharmacol Res. 2022;182:106331. doi:10.1016\/j.phrs.2022.106331","DOI":"10.1016\/j.phrs.2022.106331"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"8. Kurosaka D, Hirai K, Nishioka M, et al. Clinical significance of serum levels of vascular endothelial growth factor, angiopoietin-1, and angiopoietin-2 in patients with rheumatoid arthritis. J Rheumatol. 2010;37(6):1121-1128. doi:10.3899\/jrheum.090941","DOI":"10.3899\/jrheum.090941"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"9. Nadar SK, Blann AD, Lip GY. Plasma and platelet-derived vascular endothelial growth factor and angiopoietin-1 in hypertension: effects of antihypertensive therapy. J Intern Med. 2004;256(4):331-337. doi:10.1111\/j.1365-2796.2004.01367.x","DOI":"10.1111\/j.1365-2796.2004.01367.x"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"10. Thurston G, Daly C. The complex role of angiopoietin-2 in the angiopoietin-tie signaling pathway. Cold Spring Harb Perspect Med. 2012;2(9):a006550. doi:10.1101\/cshperspect.a006650","DOI":"10.1101\/cshperspect.a006650"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"11. Morisada T, Kubota Y, Urano T, Suda T, Oike Y. Angiopoietins and angiopoietin-like proteins in angiogenesis. Endothelium. 2006;13(2):71-79. doi:10.1080\/10623320600697989","DOI":"10.1080\/10623320600697989"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"12. Khairoun M, van den Heuvel M, van den Berg BM, et al. Early systemic microvascular damage in pigs with atherogenic diabetes mellitus coincides with renal angiopoietin dysbalance. PLoS One. 2015;10(4):e0121555. doi:10.1371\/journal.pone.0121555","DOI":"10.1371\/journal.pone.0121555"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"13. Abecassis M, Bartlett ST, Collins AJ, et al. Kidney transplantation as primary therapy for end-stage renal disease: a National Kidney Foundation\/Kidney Disease Outcomes Quality Initiative (NKF\/KDOQITM) conference. Clin J Am Soc Nephrol. 2008;3(2):471-480. doi:10.2215\/CJN.05021107","DOI":"10.2215\/CJN.05021107"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"14. Huang E, Segev DL, Rabb H. Kidney transplantation in the elderly. Semin Nephrol. 2009;29(6):621-635. doi:10.1016\/j.semnephrol.2009.07.011","DOI":"10.1016\/j.semnephrol.2009.07.011"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"15. David S, K\u00fcmpers P, Lukasz A, et al. Circulating angiopoietin-2 levels increase with progress of chronic kidney disease. Nephrol Dial Transplant. 2010;25(8):2571-2576. doi:10.1093\/ndt\/gfq060","DOI":"10.1093\/ndt\/gfq060"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"16. Ou X, Gao JH, He LH, et al. Angiopoietin-1 aggravates atherosclerosis by inhibiting cholesterol efflux and promoting inflammatory response. Biochim Biophys Acta Mol Cell Biol Lipids. 2020;1865(2):158535. doi:10.1016\/j.bbalip.2019.158535","DOI":"10.1016\/j.bbalip.2019.158535"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"17. Bae H, Hong KY, Lee CK, et al. Angiopoietin-2-integrin \u03b15\u03b21 signaling enhances vascular fatty acid transport and prevents ectopic lipid-induced insulin resistance. Nat Commun. 2020;11(1):2980. doi:10.1038\/s41467-020-16795-4","DOI":"10.1038\/s41467-020-16795-4"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"18. Kersten S. New insights into angiopoietin-like proteins in lipid metabolism and cardiovascular disease risk. Curr Opin Lipidol. 2019;30(3):205-211. doi:10.1097\/MOL.0000000000000600","DOI":"10.1097\/MOL.0000000000000600"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"19. Kersten S. Angiopoietin-like 3 in lipoprotein metabolism. Nat Rev Endocrinol. 2017;13(12):731-739. doi:10.1038\/nrendo.2017.119","DOI":"10.1038\/nrendo.2017.119"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"20. Kersten S. Role and mechanism of the action of angiopoietin-like protein ANGPTL4 in plasma lipid metabolism. J Lipid Res. 2021;62:100150. doi:10.1016\/j.jlr.2021.100150","DOI":"10.1016\/j.jlr.2021.100150"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"21. Ahmed A, Fujisawa T. Multiple roles of angiopoietins in atherogenesis. Curr Opin Lipidol. 2011;22(5):380-385. doi:10.1097\/MOL.0b013e32834b26b3","DOI":"10.1097\/MOL.0b013e32834b26b3"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"22. Gamble JR, Drew J, Trezise L, et al. Angiopoietin-1 is an antipermeability and anti-inflammatory agent in vitro and targets cell junctions. Circ Res. 2000;87(7):603-607. doi:10.1161\/01.res.87.7.603","DOI":"10.1161\/01.RES.87.7.603"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"23. Arai F, Hirao A, Ohmura M, et al. Tie2\/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche. Cell. 2004;118(2):149-161. doi:10.1016\/j.cell.2004.07.004","DOI":"10.1016\/j.cell.2004.07.004"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"24. Zhang CC, Kaba M, Ge G, et al. Angiopoietin-like proteins stimulate ex vivo expansion of hematopoietic stem cells. Nat Med. 2006;12(2):240-245. doi:10.1038\/nm1342","DOI":"10.1038\/nm1342"},{"key":"ref24","unstructured":"25. Szmigielska-Kaplon A, Krawczynska A, Czemerska M, et al. Angiopoietins in haematopoietic stem cell mobilisation in patients with haematological malignancies. Blood Transfus. 2015;13(1):102-108. doi:10.2450\/2014.0002-14"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"26. Yu X, Ye F. Role of angiopoietins in development of cancer and neoplasia associated with viral infection. Cells. 2020;9(2):457. doi:10.3390\/cells9020457","DOI":"10.3390\/cells9020457"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"27. Tan MJ, Teo Z, Sng MK, Zhu P, Tan NS. Emerging roles of angiopoietin-like 4 in human cancer. Mol Cancer Res. 2012;10(6):677-688. doi:10.1158\/1541-7786.MCR-11-0519","DOI":"10.1158\/1541-7786.MCR-11-0519"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"28. Tsai T, Alwees M, Asaad M, et al. Increased angiopoietin-1 and -2 levels in human vitreous are associated with proliferative diabetic retinopathy. PLoS One. 2023;18(1):e0280488. doi:10.1371\/journal.pone.0280488","DOI":"10.1371\/journal.pone.0280488"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"29. Rasul S, Reiter MH, Ilhan A, Lampichler K, Wagner L, Kautzky-Willer A. Circulating angiopoietin-2 and soluble Tie-2 in type 2 diabetes mellitus: a cross-sectional study. Cardiovasc Diabetol. 2011;10:55. doi:10.1186\/1475-2840-10-55","DOI":"10.1186\/1475-2840-10-55"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"30. Figueroa-Vega N, D\u00edaz A, Adrados M, et al. The association of the angiopoietin\/Tie-2 system with the development of metastasis and leukocyte migration in neuroendocrine tumors. Endocr Relat Cancer. 2010;17(4):897-908. doi:10.1677\/ERC-10-0020","DOI":"10.1677\/ERC-10-0020"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"31. Abu-Farha M, Abubaker J, Noronha F, et al. Lack of associations between betatrophin\/ANGPTL8 level and C-peptide in type 2 diabetic subjects. Cardiovasc Diabetol. 2015;14:112. doi:10.1186\/s12933-015-0277-1","DOI":"10.1186\/s12933-015-0277-1"},{"key":"ref31","unstructured":"32. You QY, Zhuge FY, Zhu QQ, Si XW. Effects of laser photocoagulation on serum angiopoietin-1, angiopoietin-2, angiopoietin-1\/angiopoietin-2 ratio, and soluble angiopoietin receptor Tie-2 levels in type 2 diabetic patients with proliferative diabetic retinopathy. Int J Ophthalmol. 2014;7(4):648-653. doi:10.3980\/j.issn.2222-3959.2014.04.11"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"33. Xu A, Lam MC, Chan KW, et al. Angiopoietin-like protein 4 decreases blood glucose and improves glucose tolerance but induces hyperlipidemia and hepatic steatosis in mice. Proc Natl Acad Sci U S A. 2005;102(17):6086-6091. doi:10.1073\/pnas.0408452102","DOI":"10.1073\/pnas.0408452102"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"34. Qaddoumi MG, Alanbaei M, Hammad MM, et al. Investigating the role of myeloperoxidase and angiopoietin-like protein 6 in obesity and diabetes. Sci Rep. 2020;10(1):6170. doi:10.1038\/s41598-020-63149-7","DOI":"10.1038\/s41598-020-63149-7"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"35. Fan KC, Wu HT, Wei JN, et al. Serum angiopoietin-like protein 6, risk of type 2 diabetes, and response to hyperglycemia: a prospective cohort study. J Clin Endocrinol Metab. 2020;105(5):dgaa103. doi:10.1210\/clinem\/dgaa103","DOI":"10.1210\/clinem\/dgaa103"},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"36. Christopoulou E, Elisaf M, Filippatos T. Effects of angiopoietin-like 3 on triglyceride regulation, glucose homeostasis, and diabetes. Dis Markers. 2019;2019:6578327. doi:10.1155\/2019\/6578327","DOI":"10.1155\/2019\/6578327"},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"37. Hoang Thi M, Dang Thanh C, Huynh Quang T. The correlation between angiopoietin-like 3 and metabolic markers of some lipid and glucose in type 2 diabetes mellitus patients at the first diagnosis. Diabetes Metab Syndr Obes. 2022;15:3329-3337. doi:10.2147\/DMSO.S383234","DOI":"10.2147\/DMSO.S383234"},{"key":"ref37","doi-asserted-by":"publisher","unstructured":"38. Abu-Farha M, Abubaker J, Al-Khairi I, et al. Circulating angiopoietin-like protein 8 (betatrophin) association with HsCRP and metabolic syndrome. Cardiovasc Diabetol. 2016;15:25. doi:10.1186\/s12933-016-0346-0","DOI":"10.1186\/s12933-016-0346-0"},{"key":"ref38","doi-asserted-by":"publisher","unstructured":"39. Liu J, Nair V, Zhao YY, et al. Multi-scalar data integration links glomerular angiopoietin-tie signaling pathway activation with progression of diabetic kidney disease. Diabetes. 2022;71(12):2664-2676. doi:10.2337\/db22-0169","DOI":"10.2337\/db22-0169"},{"key":"ref39","doi-asserted-by":"publisher","unstructured":"40. Gnudi L. Angiopoietins and diabetic nephropathy. Diabetologia. 2016;59(8):1616-1620. doi:10.1007\/s00125-016-3995-3","DOI":"10.1007\/s00125-016-3995-3"},{"key":"ref40","doi-asserted-by":"publisher","unstructured":"41. Rangasamy S, Srinivasan R, Maestas J, McGuire PG, Das A. A potential role for angiopoietin 2 in the regulation of the blood-retinal barrier in diabetic retinopathy. Investig Ophthalmol Visual Sci. 2011;52(6):3784-3791. doi:10.1167\/iovs.10-6386","DOI":"10.1167\/iovs.10-6386"},{"key":"ref41","doi-asserted-by":"publisher","unstructured":"42. Blann AD, Brown JE, Heitmar R. Angiogenesis, metabolism, endothelial and platelet markers in diabetes and cardiovascular disease. Br J Biomed Sci. 2022;79:10313. doi:10.3389\/bjbs.2022.10313","DOI":"10.3389\/bjbs.2022.10313"},{"key":"ref42","doi-asserted-by":"publisher","unstructured":"43. Chen JX, Stinnett A. Disruption of Ang-1\/Tie-2 signaling contributes to the impaired myocardial vascular maturation and angiogenesis in type II diabetic mice. Arterioscler Thromb Vasc Biol. 2008;28(9):1606-1613. doi:10.1161\/ATVBAHA.108.169235","DOI":"10.1161\/ATVBAHA.108.169235"},{"key":"ref43","doi-asserted-by":"publisher","unstructured":"44. Collazos-Alem\u00e1n JD, Gnecco-Gonz\u00e1lez S, Jaramillo-Zarama B, Jim\u00e9nez-Mora MA, Mendivil CO. The role of angiopoietins in neovascular diabetes-related retinal diseases. Diabetes Ther. 2022;13(11-12):1811-1821. doi:10.1007\/s13300-022-01326-9","DOI":"10.1007\/s13300-022-01326-9"},{"key":"ref44","doi-asserted-by":"publisher","unstructured":"45. Wang Y, Zheng Z, Yang Y, et al. Angiopoietin-like 2 is a potential biomarker for diabetic foot patients. BMC Endocr Disord. 2020;20(1):178. doi:10.1186\/s12902-020-00657-7","DOI":"10.1186\/s12902-020-00657-7"},{"key":"ref45","doi-asserted-by":"publisher","unstructured":"46. Cinkajzlov\u00e1 A, Mr\u00e1z M, Lacinov\u00e1 Z, et al. Angiopoietin-like protein 3 and 4 in obesity, type 2 diabetes mellitus, and malnutrition: the effect of weight reduction and realimentation. Nutr Diabetes. 2018;8:21. doi:10.1038\/s41387-018-0032-2","DOI":"10.1038\/s41387-018-0032-2"},{"key":"ref46","doi-asserted-by":"publisher","unstructured":"47. Park CY, Moon J, Jo G, et al. The association between genetic variants of angiopoietin-like 3 and risk of diabetes mellitus is modified by dietary factors in Koreans. Sci Rep. 2019;9:766. doi:10.1038\/s41598-018-36581-z","DOI":"10.1038\/s41598-018-36581-z"},{"key":"ref47","doi-asserted-by":"publisher","unstructured":"48. McCulloch LJ, Bramwell LR, Knight B, Kos K. Circulating and tissue specific transcription of angiopoietin-like protein 4 in human type 2 diabetes. Metabolism. 2020;106:154192. doi:10.1016\/j.metabol.2020.154192","DOI":"10.1016\/j.metabol.2020.154192"},{"key":"ref48","doi-asserted-by":"publisher","unstructured":"49. Park HS, Kim HZ, Park JS, et al. \u03b2-Cell-derived angiopoietin-1 regulates insulin secretion and glucose homeostasis by stabilizing the islet microenvironment. Diabetes. 2019;68(4):774-786. doi:10.2337\/db18-0864","DOI":"10.2337\/db18-0864"},{"key":"ref49","doi-asserted-by":"publisher","unstructured":"50. Giacco F, Brownlee M. Oxidative stress and diabetic complications. Circ Res. 2010;107(9):1058-1070. doi:10.1161\/CIRCRESAHA.110.223545","DOI":"10.1161\/CIRCRESAHA.110.223545"},{"key":"ref50","doi-asserted-by":"publisher","unstructured":"51. Okamoto T, Yamagishi S, Inagaki Y, et al. Angiogenesis induced by advanced glycation end products and its prevention by cerivastatin. FASEB J. 2002;16(14):1928-1930. doi:10.1096\/fj.02-0030fje","DOI":"10.1096\/fj.02-0030fje"},{"key":"ref51","doi-asserted-by":"publisher","unstructured":"52. Lobov IB, Brooks PC, Lang RA. Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo. Proc Natl Acad Sci U S A. 2002;99(17):11205-11210. doi:10.1073\/pnas.172161899","DOI":"10.1073\/pnas.172161899"},{"key":"ref52","doi-asserted-by":"publisher","unstructured":"53. Lim HS, Blann AD, Chong AY, Freestone B, Lip GY. Plasma vascular endothelial growth factor, angiopoietin-1, and angiopoietin-2 in diabetes: Implications for cardiovascular risk and effects of multifactorial intervention. Diabetes Care. 2004;27(12):2918-2924. doi:10.2337\/diacare.27.12.2918","DOI":"10.2337\/diacare.27.12.2918"},{"key":"ref53","doi-asserted-by":"publisher","unstructured":"54. Azadi SM, Fadaei R, Omid-Shafaat R, Hosseini J, Moradi N. Elevated angiopoietin-like protein 3 serum levels in diabetic nephropathy patients and its association with renal function and lipid profile. BMC Nephrol. 2023;24(1):172. doi:10.1186\/s12882-023-03214-1","DOI":"10.1186\/s12882-023-03214-1"},{"key":"ref54","doi-asserted-by":"publisher","unstructured":"55. Issa YA, Abd ElHafeez SS, Amin NG. The potential role of angiopoietin-like protein-8 in type 2 diabetes mellitus: A possibility for predictive diagnosis and targeted preventive measures? EPMA J. 2019;10(3):239-248. doi:10.1007\/s13167-019-00180-3","DOI":"10.1007\/s13167-019-00180-3"},{"key":"ref55","doi-asserted-by":"publisher","unstructured":"56. Yang L, Song J, Zhang X, et al. Association of serum angiopoietin-like protein 8 with albuminuria in type 2 diabetic patients: results from the GDMD Study in China. Front Endocrinol (Lausanne). 2018;9:414. doi:10.3389\/fendo.2018.00414","DOI":"10.3389\/fendo.2018.00414"},{"key":"ref56","doi-asserted-by":"publisher","unstructured":"57. Seyhanli Z, Seyhanli A, Aksun S, Pamuk BO. Evaluation of serum angiopoietin-like protein 2 (ANGPTL-2), angiopoietin-like protein 8 (ANGPTL-8), and high-sensitivity C-reactive protein (hs-CRP) levels in patients with gestational diabetes mellitus and normoglycemic pregnant women. J Matern Fetal Neonatal Med. 2022;35(25):5647-5652. doi:10.1080\/14767058.2021.1888919","DOI":"10.1080\/14767058.2021.1888919"}],"container-title":["Experimental and Clinical Transplantation"],"original-title":[],"deposited":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T10:24:05Z","timestamp":1785320645000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ectrx.org\/detail\/supplement\/2026\/24\/6\/2\/395\/0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":57,"journal-issue":{"issue":"Supp 2","published-print":{"date-parts":[[2026,7]]}},"URL":"https:\/\/doi.org\/10.6002\/ect.mesot2025.p191","relation":{},"ISSN":["1304-0855","2146-8427"],"issn-type":[{"value":"1304-0855","type":"print"},{"value":"2146-8427","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7]]}}}